Tennessee Valley Asset Management Partners purchased a new position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,394 shares of the company’s stock, valued at approximately $83,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its stake in shares of DocuSign by 2.4% in the third quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock worth $881,260,000 after buying an additional 482,472 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of DocuSign by 147.4% in the third quarter. AQR Capital Management LLC now owns 1,908,500 shares of the company’s stock worth $80,157,000 after buying an additional 1,136,948 shares during the last quarter. Jupiter Asset Management Ltd. increased its stake in DocuSign by 166.4% during the third quarter. Jupiter Asset Management Ltd. now owns 1,344,703 shares of the company’s stock valued at $56,478,000 after purchasing an additional 839,883 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in DocuSign by 77.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company’s stock valued at $51,057,000 after purchasing an additional 531,682 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its stake in DocuSign by 32.7% during the third quarter. Robeco Institutional Asset Management B.V. now owns 724,314 shares of the company’s stock valued at $30,421,000 after purchasing an additional 178,299 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.
Insider Buying and Selling at DocuSign
In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Stephen Shute sold 15,109 shares of the company’s stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $57.02, for a total transaction of $861,515.18. Following the completion of the sale, the insider now directly owns 8,959 shares of the company’s stock, valued at $510,842.18. The disclosure for this sale can be found here. In the last three months, insiders sold 54,871 shares of company stock valued at $3,176,199. 17.80% of the stock is owned by insiders.
DocuSign Stock Up 0.3 %
DocuSign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings data on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.06. The business had revenue of $712.39 million during the quarter, compared to the consensus estimate of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. Equities analysts anticipate that DocuSign, Inc. will post 0.86 EPS for the current year.
Analysts Set New Price Targets
Several analysts have weighed in on the stock. Royal Bank of Canada reiterated a “sector perform” rating and set a $59.00 target price on shares of DocuSign in a research note on Friday, April 12th. JMP Securities reiterated a “market outperform” rating and set a $84.00 target price on shares of DocuSign in a research note on Friday, April 12th. Wells Fargo & Company lowered their price target on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research report on Monday, February 5th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research report on Friday, April 12th. Finally, Morgan Stanley upgraded shares of DocuSign from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $60.25.
View Our Latest Stock Report on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- Stock Market Sectors: What Are They and How Many Are There?
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Why Invest in 5G? How to Invest in 5G Stocks
- Merger or Not, Albertson’s Companies is a Good Buy
- With Risk Tolerance, One Size Does Not Fit All
- 3 Cheap Stocks That Shouldn’t Be So
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.